ARCHIVES

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

This article is from The Cancer Letter archive.

Vol. 16 No. 31 | August 3, 1990

Download PDF Visit The Full Archive

Related Articles

ImClone Protocol Generates More Questions Than Answers

March 8, 2002

Wynder’s Low Fat Adjuvant Breast Cancer Study Finally Funded

October 21, 1988

Generic Paclitaxel Approval Withstands Court Challenge.

May 4, 2001

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

Funding opportunities listed.

July 16, 2004

Sen. Brown Introduces Bill on Clinical Trials Coverage

April 3, 2009